SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-025483
Filing Date
2017-04-24
Accepted
2017-04-24 16:53:37
Documents
3
Effectiveness Date
2017-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-10907_5defa14a.htm DEFA14A 32167
2 GRAPHIC g109075bgi001.gif GRAPHIC 174657
3 GRAPHIC g109075bgi002.gif GRAPHIC 149736
  Complete submission text file 0001104659-17-025483.txt   480088
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37719 | Film No.: 17778748
SIC: 2834 Pharmaceutical Preparations